Trinity biotech plc to announce q4 and fiscal year 2023 financial results

Dublin, ireland, march 28, 2024 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2023 on thursday, april 4, 2024 at 8:00 am et. conference call dial-in & webcast information date: thursday, april 4, 2024 time: 8:00 am et united states: 1-877-407-0784 international: 1-201-689-8560 conference id: 13745604 call me™: https://callme.viavid.com/viavid/?callme=true&passcode=13743417&h=true&info=company-email&r=true&b=6 webcast click here for webcast     about trinity biotech trinity biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market.
TRIB Ratings Summary
TRIB Quant Ranking